卢华群

华群 卢 is currently the sales leader for Northern China in the inflammation and immunology division at Pfizer, a position they have held since 2023. From 2021 to 2022, 华群 served as the deputy general manager of tumor marketing at Shanghai Junshi Bioscience, where they successfully enhanced team performance and market strategies. Prior to that, between 2017 and 2021, 华群 was a senior sales director at Roche, achieving notable growth in sales across multiple regions. Their career began in 2004 at AstraZeneca, where they rose through various sales and managerial positions, including a team lead role that earned them multiple awards for performance excellence. 华群 earned an associate degree in Accounting from Chinese Textile University from 1995 to 1997.